- Expert speakers from pioneering biotech and pharma companies, including Roche, Eisai, AbbVie, Neurolief and LabCorp, healthcare providers, and commercial & private payers
- Two full days of content tackling Navigating Formulary Access, Package Insert Constraints, and Payer Expectations in CNS Therapeutics and Advancing Reimbursement and Integration for CNS Biomarkers
- Interactive roundtables and networking sessions to connect industry leaders and accelerate patient access to vital therapeutics in time-sensitive conditions
- Cutting edge innovations from umbrella trials and combination therapies to embedding market access strategy from Phase II onward
- Exclusive panel discussions discussing lessons learned from successfully commercialized CNS therapeutics
Having trouble downloading the brochure? Let us know and we’ll email it to you instead
Companies on the Program:
